Pharmaceutical glass interactions: A review of possibilities

Journal of Pharmaceutical Sciences and Research

Volumn 8, Issue 2, 2016, Pages 103-111

  Pillai, Sumitra A ^a,b   Chobisa, Dhawal ^a   Urimi, Dileep ^a   Ravindra, Nagasuri ^c  

^a DR REDDY'S LABORATORIES LTD   (India)

^b India drharshalortho gmailcom   (India)

^c Chilkur Balaji College of Pharmacy   (India)

Author keywords

Delamination; Glass; Leachables and extractables; Particulate matter

Indexed keywords

ALBUMIN; ALUMINUM; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMITRIPTYLINE; ARSENIC; ARSINE; ASCORBIC ACID; BARIUM SULFATE; BORATE GLASS; BOROSILICATE GLASS; BUFFER; CITRATE SODIUM; GLASS; GLUCOSE; HEPARIN; IRON; METAL ION; MINODRONIC ACID; SILICATE; SODA LIME GLASS; THIOMERSAL; UNCLASSIFIED DRUG;

ATOMIC ABSORPTION SPECTROMETRY; ATOMIC FORCE MICROSCOPY; CHEMICAL INTERACTION; CRYSTALLIZATION; DRUG CONTAMINATION; DRUG DEGRADATION; DRUG FORMULATION; DRUG MANUFACTURE; GLASS BOTTLE; HUMAN; ION EXCHANGE; MATERIAL COATING; PACKAGING; PH; PHYSICAL CHEMISTRY; REVIEW; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; STORAGE; X RAY ANALYSIS;

EID: 84958970914     PISSN: None     EISSN: 09751459     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Guidelines on packaging for pharmaceutical products, 2002. WHO Technical Report Series. 2013, 128-130.
2. Borchert, S. J., Ryan, M. M., Davison, R. L., Speed, W., PDA J. Pharm. Sci. Technol. 1989, 43, 67-79.
3. Nema, S., Ludwig, J D., Pharmaceutical Dosage Forms-Parenteral Medications, CRC Press. 2010, 1.
4. Sacha, G. A., Saffell-Clemmer, W., Abram, K., Akers, M. J., Pharm. Dev. Technol. 2010, 15, 6-34.
5. Akala, E. O., Effect of Packaging on Stability of Drugs and Drug Products, Wiley, New York, 2010.
6. Kumar, S., Int. J. Res. Pharm. Biomed. Sci. 2013, 4, 1413.
7. Food, Administration D. Advisory to drug manufacturers: formation of glass lamellae in certain injectable drugs. 2011.
8. Höger, K., Investigations on protein adsorption to coated glass vials: lmu; 2014.
9. Iacocca, R.G., Allgeier, M., J. Mater. Sci. 2007, 42, 801-811.
10. Ennis, R. D., Pritchard, R., Nakamura, C., Coulon, M., Yang, T., Visor, G. C., et al. Pharm. Dev. Technol. 2001, 6, 393-405.
11. Iacocca, R. G., Toltl, N., Allgeier, M., Bustard, B., Dong, X., Foubert, M., et al. AAPS Pharm SciTech. 2010, 11, 1340.
12. Glausch, A., Loffler, R., Sigg, J., Pharmaceutical products comprising bisphosphonates. United States patent US 7,932,241 B2. 2011.
13. Mirtallo, J. M., J. Parenter. Enteral Nutr. 2010, 34, 346-347.
14. Gura, K. M., Nutrition. 2010, 26, 585-594.
15. Greger, J. L., Sutherland, J. E., Yokel, R., Crit. Rev. Clin. Lab. Sci. 1997, 34, 439-474.
16. Bohrer, D., do Nascimento, P. C., Binotto, R., Carlesso, R., J. Trace Elem. Med. Biol. 2001, 15, 103-108.
17. Ogawa, T., Miyajima, M., Wakiyama, N., Terada, K., Drug Dev. Ind. Pharm. 2013, 41, 315-321.
18. Ogawa, T., Miyajima, M., Wakiyama, N., Terada, K., Chem. Pharm. Bull. 2013, 61, 539-545.
19. Bohrer, D., do Nascimento, P. C., Binotto, R., Pomblum, S. C., J. Trace Elem. Med. Biol. 2001, 15, 95-101.
20. Bohrer, D., do Nascimento, P. C., Binotto, R., Becker, E., J. Trace Elem. Med. Biol. 2003, 17, 107-115.
21. Veiga, M., Bohrer, D., Noremberg, S., Mattiazzi, P., do Nascimento, P. C., de Carvalho, L. M., Renal failure. 2013, 35, 391-405.
22. Nakamura, K., Tanaka, T., Saito, K., Yokohama, S., Sonobe, T., Int. J. Pharm. 2001, 222, 91-99.
23. Nakamura, K., Yokohama, S., Sonobe, T., Int. J. Pharm. 2002, 241, 65-71.
24. Kayasth, S., Swain, K., J. Radioanal. Nucl. Chem. 2004, 259, 293-304.
25. Bohrer, D., Becker, E., Nascimento, P.C., Morschbacher, V., De Carvalho, L. M., da Silva Marques, M., Int. J. Pharm. 2006, 315, 24-29.
26. Bohrer, D., do Nascimento, P. C., Becker, E., de Carvalho, L. M., Dessuy, M., J. Parenter. Enteral Nutr. 2005, 29, 1-7.
27. Boddapati, S., Butler, L. D., Im, S., Deluca, P. P., J. Pharm. Sci. 1980, 69, 608-610.
28. Aoyama, T., Horioka, M., Chem. Pharm. Bull. 1987, 35, 1223-1227.
29. Bohrer, D., Morschbacher, V., Viana, C., do Nascimento, P. C., de Carvalho, L. M., e-SPEN Journal. 2014, 9, 223-227.
30. Mendenhall, D. W., Drug Dev. Ind. Pharm. 1984, 10, 1297-1342.
31. Enever, R., Li Wan Po, A., Shotton, E., J. Pharm. Sci. 1977, 66, 1087-1099.
32. Kassem, M., Kassem, A., Ammar, H., Pharm. Acta Helv. 1969, 44, 611-623.
33. Lipper, R., Nevola, M., Influence of Amber Glass on the Decomposition of Thiomerosol in Aqueous solution. paper presented to 31st National APhA Academy of Pharmaceutical Sciences 31st Meeting, Orlando.
34. Reed, R. A., Harmon, P., Manas, D., Wasylaschuk, W., Galli, C., Biddell, R., et al. PDA J. Pharm. Sci. Technol. 2003, 57, 351-368.
35. Quarry, M. A., Sebastian, D. S., Diana, F., J. Pharm. Biomed. Anal. 2002, 30, 99-104.
36. Bohrer, D., Bortoluzzi, F., Nascimento, P. C., Carvalho, L. M., Ramirez, A. G., Int. J. Pharm. 2008, 355, 174-183.
37. Bacon, F. R., Raggon, F. C., J. Am. Ceram. Soc. 1959, 42, 199-205.
38. Geary, T. G., Akood, M.A., Jensen, J.B., Am. J. Trop. Med. Hyg. 1983, 32, 19-23.
39. Ciarlone, A. E., Fry, B.W., Ziemer, D. M., Microchem. J. 1990, 42, 250-255.
40. Song, D., Hsu, L. F., Au, J. L. S., J. Pharm. Sci. 1996, 85, 29-31.
41. Thakker, K. D., Higuchi, T., Sternson, L. A., J. Pharm. Sci. 1979, 68, 93-105.
42. Mathes, J., Friess, W., Eur. J. Pharm. Biopharm. 2011, 78, 239-247.
43. Qadry, S., Roshdy, T., Char, H., Del Terzo, S., Tarantino, R., Moschera, J., Int. J. Pharm. 2003, 252, 207-212.
44. Eu, B., Cairns, A., Ding, G., Cao, X., Wen, Z.Q., J. Pharm. Sci. 2011, 100, 1663-1670.
45. Schwarzenbach, M.S., Reimann, P., Thommen, V., Hegner, M., Mumenthaler, M., Schwob, J., et al. PDA J. Pharm. Sci. Technol. 2002, 56, 78-89.
46. Johnston, T.P., PDA J. Pharm. Sci. Technol. 1996, 50, 238-245.
47. Mitrano, F., Newton. D., Am. J. Health-Syst. Pharm. 1982, 39, 1491-1495.